Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. - Wikidata - wikimedia - TriplyDB

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

http://www.wikidata.org/entity/Q34405321

about

Trends in Timing of Dialysis Initiation within Versus Outside the Department of Veterans Affairs Strategies for postmarketing surveillance of drugs and devices in patients with ESRD undergoing dialysis Form CMS-2728 data versus erythropoietin claims data: implications for quality of care studies.Trends in relative mortality between Hispanic and non-Hispanic whites initiating dialysis: a retrospective study of the US Renal Data System.A comparison between physicians and computer algorithms for form CMS-2728 data reporting.Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting.Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.Underreporting of nursing home utilization on the CMS-2728 in older incident dialysis patients and implications for assessing mortality risk Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States.Patient characteristics and outcomes by GN subtype in ESRD.Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis Rural and micropolitan residence and mortality in patients on dialysis.Comparison of vascular access outcomes in patients with end-stage renal disease attributed to systemic lupus erythematosus vs. other causes: a retrospective cohort study Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System.Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy.Prevalence of pre-end-stage renal disease care and associated outcomes among urban, micropolitan, and rural dialysis patients.Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center.Kidney Transplantation Outcomes across GN Subtypes in the United States.ESRD Databases, Public Policy, and Quality of Care: Translational Medicine and Nephrology.Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.Asking dialysis patients about what they were told: a new strategy for improving access to kidney transplantation?Mortality and Allograft Loss Trends Among US Pediatric Kidney Transplant Recipients With and Without Focal Segmental Glomerulosclerosis.End-Stage Kidney Disease From Scleroderma in the United States, 1996 to 2012.Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report.Antimalarial Drugs for the Prevention of Chronic Kidney Disease in Patients with Rheumatoid Arthritis: The Importance of Controlling Chronic Inflammation?Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.A large, international study on post-transplant glomerular diseases: the TANGO project

P2860

Q27335426-77587F2B-D80D-4828-B493-C6D5E938B005 Q27694667-D364C229-6B6D-437F-B287-E93E53EEB781 Q30580993-01D7875A-69F2-40C4-9030-96FAAF98E30C Q30621295-EDA4F971-5E06-4273-94C4-A3D9A6D75CCC Q31111183-4D99982B-402B-48F7-904A-C172D7D48A71 Q33719256-D374A818-98E0-4501-90C0-8A891867113D Q35209132-431208A5-B884-49DC-B03B-C281DF607B57 Q35321704-3EF9E81A-DF7F-4694-A3E3-E07BFF1AF229 Q35534306-95BB7D09-E506-48BF-BEBC-B8F05AEEDB4C Q35583267-8F277A30-B9E6-4D10-9AAC-00E6595B8795 Q35758537-7F23D0F1-D553-498D-8D21-38647A6063B1 Q35817064-5F3FAC00-8348-465E-BDF8-4EFFDC921F8C Q35890096-9DA2E59F-E000-4F37-876B-3C5302C8E10F Q36067848-4BF94742-E10D-4462-B3C2-A2E39B70043C Q36070270-18103428-5008-40EE-911D-6FA1BE1979C3 Q36070687-19338B1F-9986-405B-9CEB-57FB01B58D9B Q36517240-0E96A212-2BEB-4B0E-9254-23EA3E10377E Q36790982-4D546E37-202C-4593-A1A2-451AE4A6FF3F Q37209361-3E6BC21C-73C4-47A3-8778-C4E145D8C08F Q37684471-D944145E-E214-4E74-8042-C731C254A4DC Q37738193-136AC8A5-85D9-4CF1-9BE3-BFEBEFDE7698 Q38840225-31DA6F51-6789-41DC-A704-C599418ADF6A Q39010402-14CF5124-768E-471B-ACA3-12C1FEA73565 Q40271260-85AE8692-252D-4B52-8463-9DC9E47D31D6 Q43030401-D38008A0-7668-4289-B659-A801FB64A78E Q47249950-F73DE13B-8C94-416B-858D-BBAFF213FAC0 Q49594527-9884BFED-ABD1-47AC-BA51-33ACBF8FBD1F Q50085445-DDB943BB-E235-4E46-A519-A6511395CA6F Q52718965-86866FA4-ABBF-4A0A-989C-DF0758264B3D Q55257355-A2A3E0BE-FF41-46C7-9656-46AA3CE27F53 Q58747177-8E647FD3-5A0D-4756-AEC1-C76F65D287B8

P2860

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

http://www.wikidata.org/entity/Q34405321

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@ast

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@en

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@nl

type

label

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@ast

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@en

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@nl

prefLabel

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@ast

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@en

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@nl

P1433

Q34405321-F6A28E95-F35D-4326-9D86-86F52A786A5C

P1476

Q34405321-50BC0445-BC92-46FA-9707-CB7177FCC07F

P2093

Q34405321-2E973015-D44E-4CCC-84D3-1784D367C02A

Q34405321-8155BD77-F109-4C4C-B7EC-7DDCC4E89F77

Q34405321-9607F16E-A223-4C5A-8C39-FB7BECEA512B

Q34405321-96542570-C305-4894-B9E2-7836F734E201

Q34405321-96B1192B-0AFC-4E44-87AA-4C0A7B882499

Q34405321-AB1CFC04-728A-4671-80B2-1AF6679612C6

Q34405321-BCB40AB6-7BB8-4C43-839C-417CBAD9DBCC

P2860

Q34405321-1FDFA58E-EE88-4BE4-A9A9-DF93ECCCFFC7

Q34405321-599DD834-5FE2-4515-907D-839E5F7C8CBF

Q34405321-5A3A39F2-E6F7-40D6-AA60-B6B7079A2870

Q34405321-630C20AB-6EF7-4074-97BD-3A8D736730BD

Q34405321-690FF955-4350-40EC-BDE0-85DE20C8259F

Q34405321-6D510ABE-8755-4947-937D-BB2E845AFFF8

Q34405321-730CFDE4-18E9-4DDA-815E-F1C67BA8EA4B

Q34405321-B801CC72-B200-45BD-BAFE-6E483AEDC379

Q34405321-BAB99A49-A7E0-424C-A75C-03D0C896D3C1

Q34405321-D6152A94-7434-414A-B38A-418E17F2A948

P304

Q34405321-D05341AC-0E34-4665-8700-E85B858FBE0A

P31

Q34405321-ADF5C0E9-37CF-43A4-8A02-7E36E0AE276A

P356

Q34405321-7ACCBC13-BDCF-4E87-8C67-6EDA69D4A759

P433

Q34405321-6B862900-A2B4-48BB-B6EC-A902CFF01C70

P478

Q34405321-860F8780-1ED2-4021-9912-EF7BE84F7081

P577

Q34405321-466D3E50-2BBB-4A8F-A531-6824E25EA9D8

P698

Q34405321-9CD87EE9-963D-4A99-9137-13DDE0F68C04

P932

Q34405321-42E8C62E-1CB9-439D-92E4-E8DC02E611FD

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases.

@en

P2093

Barbara Kenderes

http://www.w3.org/2001/XMLSchema#string

Caroline E Jennette

http://www.w3.org/2001/XMLSchema#string

J Bradley Layton

http://www.w3.org/2001/XMLSchema#string

J Charles Jennette

http://www.w3.org/2001/XMLSchema#string

Jenna Krisher

http://www.w3.org/2001/XMLSchema#string

Susan L Hogan

http://www.w3.org/2001/XMLSchema#string

William M McClellan

http://www.w3.org/2001/XMLSchema#string

P2860

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

Trends in the epidemiology of focal segmental glomerulosclerosis.

Thrombotic microangiopathy after renal transplantation in the United States.

Thrombotic microangiopathy in United States long-term dialysis patients.

Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults.

Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts.

Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.

Focal and segmental glomerulosclerosis in children: a longitudinal assessment.

Differential risk of remission and ESRD in childhood FSGS.

P304

2046-2052

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.03550410

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20688886

http://www.w3.org/2001/XMLSchema#string

P932

3001765

http://www.w3.org/2001/XMLSchema#string